Annual Report – 2019
Annual Report 2019
ASX Announcements
Appendix 3B – September 2019
Appendix 3B
Collaboration with National University Hospital Singapore
Collaboration with National University Hospital Singapore 08 August, 2019: Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the commencement of a clinical validation collaboration with National University Hospital (NUH), a leading public teaching hospital in Singapore. The aim of the clinical study is to validate Invitrocue’s Onco-PDO drug screening …
Quarterly Appendix 4C and Business updates
Quarterly Appendix 4C and Business updates
Invitrocue Appoints Global Insurance Advisor
IVQ Appoints Global Insurance Advisor 06 May, 2019: Innovative life sciences company Invitrocue Limited (ASX: IVQ), (‘Invitrocue’ or ‘the Company’), is please to announce the appointment of Dr Sharifuddin Abdul Wahab as Global Insurance Advisor. In his role at Invitrocue, Dato Dr Wahab will advise and support the Company’s global insurance strategy for its Onco …
Quarterly Appendix 4C and Business updates
Quarterly Appendix 4C and Business updates
Appendix 3B – March 2019
Appendix 3B
Cleansing Statement – April 2019
Cleaning Statement
Appendix 3Z – Jamie Khoo – March 2019
Appendix 3Z
Appendix 3X – Kit Wei Lui – March 2019
Appendix 3X